ClinicalTrials.Veeva

Menu

BRUSH Sign: Radiolographic Marker of Cerebral Infarctus Prognosis

F

Fondation Hôpital Saint-Joseph

Status

Completed

Conditions

Cerebral Infarction

Treatments

Diagnostic Test: Brush sign

Study type

Observational

Funder types

Other

Identifiers

NCT03467269
BRUSH SIGN

Details and patient eligibility

About

Today the treatment of ischemic stroke in acute phase is based on medicinal or endovascular revascularization. Cerebral MRI sequences help the diagnostic. This procedure uses deoxyhemoglobin as an endogenous tracer. This is also a scorer of cerebral ischemia and the increase lets visualized transcerebral veins in the suffering zone giving a brush aspect. Several studies show the interest of this sign and conclude that deoxyhemoglobin presence is a predictive factor of cerebral ischemia. The aim of the study is to evaluate this brush-sign and correlate it with the prognosis retrospectively.

Enrollment

250 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age>18 years old
  • hospitalized for cerebral infarction
  • MCA territory
  • MRI within 24hours
  • Sequence of magnetic susceptibility (SWAN)

Exclusion criteria

  • Incomplete cerebral infarct
  • MRI not possible

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems